Cargando…
Obesity, diabetes mellitus, and cardiometabolic risk: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2023
BACKGROUND: This Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) is intended to provide clinicians an overview of type 2 diabetes mellitus (T2DM), an obesity-related cardiometabolic risk factor. METHODS: The scientific support for this CPS is based upon published citations and c...
Autores principales: | Bays, Harold Edward, Bindlish, Shagun, Clayton, Tiffany Lowe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661981/ https://www.ncbi.nlm.nih.gov/pubmed/37990743 http://dx.doi.org/10.1016/j.obpill.2023.100056 |
Ejemplares similares
-
Cancer and Obesity: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022
por: Lazarus, Ethan, et al.
Publicado: (2022) -
Thirty Obesity Myths, Misunderstandings, and/or Oversimplifications: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022
por: Bays, Harold Edward, et al.
Publicado: (2022) -
Stress, psychiatric disease, and obesity: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022
por: Christensen, Sandra M., et al.
Publicado: (2022) -
Nonalcoholic fatty liver disease and obesity: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022
por: Karjoo, Sara, et al.
Publicado: (2022) -
Concomitant medications, functional foods, and supplements: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022
por: Tondt, Justin, et al.
Publicado: (2022)